“The effectiveness of the vaccine against malaria is insufficient”

François Nosten, malaria expert and professor at the University of Oxford (here on May 19, in Paris). TUDAL LEGRAND/Le Figaro

MAINTENANCE – This French doctor and researcher fights against malaria in Southeast Asia, where resistance to treatment has appeared.

With more than 500,000 deaths each year, malaria (or malaria) remains one of the deadliest diseases in the world. This week, the WHO Africa office will provide an update on the most recent vaccination campaign against the disease. Even if this initiative mainly targets children, a category which represents more than three quarters of malaria deaths in the world, it is still criticized because of the disappointing effectiveness of the vaccine. François Nosten, malaria expert and professor at the University of Oxford, gives an update on the disease for the Figaro. This French doctor and researcher is also director of the SMRU (Shoklo Malaria Research Unit), in Mae Sot, Thailand, near the border with Burma.

LE FIGARO. – What about the vaccination strategy against malaria?

Pr Francois NOSTEN. – The RTS,S vaccine developed by GSK, with support from the Bill & Melinda Gates Foundation, is not working well. Its effectiveness is 30% against severe cases…

This article is for subscribers only. You have 91% left to discover.

Pushing back the limits of science is also freedom.

Keep reading your article for €0.99 for the first month

Already subscribed? Login


Leave a Comment